Track topics on Twitter Track topics that are important to you
REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- BroadVision, Inc. (NASDAQ:BVSN), a leading provider of e-business and engagement management solutions, today reported financial results for its second quarter ended June 30, 2015. Revenues for the second quarter were $2.2 million, compared with revenues of $2.5 million for the first quarter ended March 31, 2015 and $3.2 million for the comparable quarter of 2014.
License revenue for the second quarter of 2015 was $1.1 million, compared with $1.1 million for the prior quarter and $1.3 million for the comparable quarter of 2014. The majority of the second quarter license and subscription revenue was generated from the Company's BroadVision® Business Agility Suite™, Commerce Agility Suite™, QuickSilver™, and Clearvale® solutions. Revenue during the quarter was generated from sales to both new and existing customers.
In the second quarter of 2015, BroadVision posted net loss on a U.S. Generally Accepted Accounting Principles ("GAAP") basis of $2.5 million, or $0.51 per basic and diluted share, as compared with GAAP net loss of $3.6 million, or $0.74 per basic and diluted share, for the first quarter of 2015 and GAAP net loss of $2.3 million, or $0.49 per basic and diluted share, for the comparable quarter of 2014.
As of June 30, 2015 the Company had $35.3 million of cash and cash equivalents and short-term investments, compared to a combined balance of $36.3 million as of March 31, 2015 and $43.9 million as of June 30, 2014.
"In Q2, we expanded the worldwide user base for Vmoso to over 100,000 and established partnerships in several key markets to extend our global presence," said Dr. Pehong Chen, President and CEO of BroadVision. "Based on the positive feedback and validation we continue to receive from customers and users, we believe Vmoso as a mobile-centric unified business communication, collaboration, and engagement platform, delivered through a secure private cloud, will generate significant value for enterprises across numerous target industries, while enabling us to achieve our business objectives."
Conference Call Information
BroadVision management will host a conference call today, Friday, July 24, 2015, at 2:00PM Pacific Daylight Time (PDT). The conference call may be accessed by dialing: 1-888-424-8151, with pin code 6776924#. Callers outside North America should call +1-847-585-4422 to be connected. These numbers can be accessed 15 minutes before the call begins, as well as during the call. A web replay will also be available following the call on the Company's website.
Driving innovation since 1993, BroadVision (NASDAQ:BVSN) provides e-business solutions that enable the enterprise and its employees, partners, and customers to stay actively engaged, socially connected, and universally organized to achieve greater business results. BroadVision® solutions—including Vmoso for virtual, mobile, and social business collaboration, and Clearvale for enterprise social networking—are available globally in the cloud via the Web and mobile applications. Visit www.BroadVision.com for more details.
BroadVision, Business Agility Suite, Commerce Agility Suite, QuickSilver, and Clearvale are trademarks or registered trademarks of BroadVision, Inc. in the United States and other countries. All other company names, product names, and marks are the property of their respective owners.
The BroadVision logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5621
Information Concerning Forward-Looking Statements
Information in this release that involves expectations, beliefs, hopes, plans, intentions or strategies regarding the future, including statements regarding value creation and our ability to meet business objectives, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, which forward-looking statements involve risk and uncertainties. All forward-looking statements included in this release are based upon information available to BroadVision as of the date of this release, and BroadVision assumes no obligation to update or correct any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from BroadVision's current expectations. Various factors and risks associated with BroadVision's business are discussed in its most recent annual report on Form 10-K and in BroadVision's quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission.
|BROADVISION, INC. AND SUBSIDIARIES|
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|June 30,||December 31,|
|Cash, cash equivalents and short-term investments||$ 35,262||$ 37,079|
|Other current assets||2,186||4,405|
|Total current assets||37,448||41,484|
|Other non-current assets||299||342|
|Total assets||$ 37,747||$ 41,826|
|LIABILITIES AND STOCKHOLDERS' EQUITY|
|Current liabilities||$ 6,086||$ 5,439|
|Other non-current liabilities||1,183||774|
|Total stockholders' equity||30,478||35,613|
|Total liabilities and stockholders' equity||$ 37,747||$ 41,826|
|BROADVISION, INC. AND SUBSIDIARIES|
|CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS|
|(In thousands, except per share data)|
|Three Months Ended||Six Months Ended|
|June 30,||June 30,|
|Software licenses||$ 1,109||$ 1,252||$ 2,196||$ 2,478|
|Cost of revenues:|
|Cost of software revenues||40||45||85||89|
|Cost of services||817||1,333||1,534||2,323|
|Total cost of revenues||857||1,378||1,619||2,412|
|Research and development||1,797||1,775||3,655||3,604|
|Sales and marketing||1,305||1,351||2,445||2,858|
|General and administrative||866||878||1,754||1,878|
|Total operating expenses||3,968||4,004||7,854||8,340|
|Other income (expense), net||143||(85)||(1,245)||(45)|
|Loss before provision for income taxes||(2,495)||(2,307)||(6,035)||(4,643)|
|Provision for income taxes||(1)||(26)||(16)||(29)|
|Net loss||$ (2,496)||$ (2,333)||$ (6,051)||$ (4,672)|
|Earnings per share, basic and diluted:|
|Basic and diluted loss per share||$ (0.51)||$ (0.49)||$ (1.25)||$ (0.98)|
|Shares used in computing:|
|Weighted average shares-basic and diluted||4,849||4,794||4,841||4,782|
CONTACT: BroadVision Contact: Peter Chu Investor Relations (650) 295-0716 x7177 Ir1@broadvision.comNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.